findmyKOL

Michael McCadden, MD

Basic profile

Dermatology

ORCIDNone on fileNPI
RegionSaint Louis, MO · MidwestSpecialtyDermatologyFocusDermatology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1990Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael McCadden is a Dermatology physician. OpenAlex indexes 5 publications with 270 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5publications

Distinct works indexed by OpenAlex.

270citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
23companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

621 S New Ballas Rd
498a
Saint Louis, MO 631418232

Telephone

314-251-3376

Registry record last updated 16 Jul 2019.

View the NPPES registry record

Industry payments

23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    46.9%
    Nitroimidazole Antimicrobial27.5%
    Metronidazole100%
    Part D57 patients
    Azole Antifungal11.8%
    Ketoconazole100%
    Part D26 patients

    + 1 more class in this area

  • Dermatology

    15.9%
    Corticosteroid11.8%
    Triamcinolone Acetonide100%
    Part D27 patients
    Oxaborole Antifungal4%
    Tavaborole100%
    Part D<11 patients
  • Respiratory

    12.6%
    RNA Synthetase Inhibitor Antibacterial8.3%
    Mupirocin100%
    Part D31 patients
    Corticosteroid4.3%
    Mometasone Furoate100%
    Part D15 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”